The single largest threat to any assessment of this author is name ambiguity. OpenAlex returns at least ten high-profile "Yun Li"-type matches, including a Yun Li with an h-index of 84 and 70,012 citations, a Li Yichong (h-index 59, 122,694 citations), and several others with h-indices between 56 and 135 . Against this backdrop, the target profile β h-index 1, 14 total citations, 4 papers β almost certainly represents a distinct, junior author, but naive database merging could inflate (or misattribute) their record. Any citation-based judgment should therefore be treated as provisional until disambiguated by affiliation, co-author network, and ORCID.
The four listed papers span iron oxide nanoparticle reproductive toxicology in male rats, nanoparticle absorption in Caco-2 intestinal models, and two studies on all-trans retinoic acid in collagen-induced arthritis and rheumatoid arthritis (synovial apoptosis/autophagy, methotrexate combination). This is a coherent early-career program in nanotoxicology and autoimmune pharmacology. However, none of the supplied claim-level evidence records correspond to these four papers β the records cover spintronics, ARP2/3/mTOR neurobiology, PEI water-treatment sponges, ALS stress granules, mosquito meta-transcriptomics, AML bioinformatics, and others β so no quantitative claim from this author's own experiments can be independently verified here. A single related record (the SMNN scRNA-seq batch-correction tool) is linked to a different "Yun Li" at UNC whose GitHub/website (yunliweb.its.unc.edu) indicates a bioinformatics group, not this author .
An h-index of 1 with 14 citations over 4 papers signals a researcher early in an independent trajectory. In fields like nanotoxicology and rheumatology, 4β7 years of post-PhD activity commonly yields such metrics without implying weak science; conversely, low metrics give little signal about experimental rigor, and nothing in the supplied data permits judging methodological quality of the four listed papers (no effect sizes, sample sizes, or quality scores are available for them). The honest conclusion: known β publication list and citation counts; inferred β early-career, toxicology/pharmacology focus; uncertain β actual scientific rigor, novelty, and whether the identity attribution itself is correct. What would change the assessment: confirmed DOIs/ORCID linking the four papers, citation trajectories of the individual papers, and full-text evidence records from these specific studies.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.